JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M611043200 on October 24, 2007

J. Biol. Chem., Vol. 283, Issue 1, 388-397, January 4, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/1/388    most recent
M611043200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujiwara, K.
Right arrow Articles by Kondo, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujiwara, K.
Right arrow Articles by Kondo, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pivotal Role of the Cyclin-dependent Kinase Inhibitor p21WAF1/CIP1 in Apoptosis and Autophagy*

Keishi Fujiwara{ddagger}1, Shigeru Daido{ddagger}1, Akitsugu Yamamoto§, Ryuji Kobayashi, Tomohisa Yokoyama{ddagger}, Hiroshi Aoki{ddagger}, Eiji Iwado{ddagger}, Naoki Shinojima{ddagger}, Yasuko Kondo{ddagger}, and Seiji Kondo{ddagger}||**2

From the {ddagger}Department of Neurosurgery, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, the §Department of Cell Biology and Bioscience, The Nagahama Institute of Bioscience and Technology, Nagahama, Shiga 526-0829, Japan, the Department of Molecular Pathology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, the ||University of Texas Graduate School of Biomedical Sciences, Houston, Texas 77030, and the **Department of Neurosurgery, Baylor College of Medicine, Houston, Texas 77030

Programmed cell death (PCD) is involved in a variety of biologic events. Based on the morphologic appearance of the cells, there are two types of PCD as follows: apoptotic (type I) and autophagic (type II). However, the molecular machinery that determines the type of PCD is poorly defined. The purpose of this study was to show whether the presence of the cyclin-dependent kinase (CDK) inhibitor p21WAF1/CIP1, a modulator of apoptosis, determines which type of PCD the cell undergoes. Treatment with C2-ceramide was associated with both the cleavage of caspase-3 and poly(ADP-ribose) polymerase and the degradation of autophagy-related Beclin 1 and Atg5 proteins, without a change in the cyclin-CDK activity, which culminated in apoptosis in p21+/+ mouse embryonic fibroblasts (MEFs). On the other hand, C2-ceramide did not cleave caspase-3 or poly(ADP-ribose) polymerase and kept Beclin 1 and Atg5 proteins stable in p21-/- MEFs, events that this time culminated in autophagy. When expression of the p21 protein was inhibited by small interfering RNA or when the overexpression of Beclin 1 or Atg5 was induced, autophagy rather than apoptosis was initiated in the p21+/+ MEFs treated with C2-ceramide. In contrast, the exogenous expression of p21 or the silencing of Beclin 1 and Atg5 with small interfering RNA increased the number of apoptotic cells and decreased the number of autophagic cells among C2-ceramide-treated p21-/- MEFs. {gamma}-Irradiation, which endogenously generates ceramide, induced a similar tendency in these MEFs. These results suggest that p21 plays an essential role in determining the type of cell death, positively for apoptosis and negatively for autophagy.


Received for publication, November 30, 2006 , and in revised form, October 24, 2007.

* This work was supported in part by a start-up fund from the University of Texas M. D. Anderson Cancer Center (to S. K.), by a generous donation from the Anthony D. Bullock III Foundation (to Y. K. and S. K.), and by Cancer Center Support Grant (CCSG)/Shared Resources CA-16672. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Both authors contributed equally to this work.

2 To whom correspondence should be addressed: Dept. of Neurosurgery, the University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Unit BSRB 1004, Houston, TX 77030. Tel.: 713-834-6215; Fax: 713-834-6257; E-mail: seikondo{at}mdanderson.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
G. Zhang, M. A. Park, C. Mitchell, T. Walker, H. Hamed, E. Studer, M. Graf, M. Rahmani, S. Gupta, P. B. Hylemon, et al.
Multiple Cyclin Kinase Inhibitors Promote Bile Acid-induced Apoptosis and Autophagy in Primary Hepatocytes via p53-CD95-dependent Signaling
J. Biol. Chem., September 5, 2008; 283(36): 24343 - 24358.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.